Saudi: Thrombosis cases associated with the AstraZeneca
Amongst all the emergence of unusual cases of thrombosis linked to several vaccines around the world, Saudi Arabia’s health authorities announced the registration of a small number of cases of blood clots linked to the “Oxford – AstraZeneca” Coronavirus vaccine.
The Saudi Food & Drug Authority concluded that blood clots associated with vaccination are very rare and the vaccine’s benefits outweigh the risks:
“The desired benefits from giving the vaccine still outweigh the possible risks, according to accepted medical information”.
The findings were examined in both scientific and technological before being submitted to professional scientific committees. Likewise, the syndrome of immune platelet deficiency and clotting associated with the AstraZeneca vaccine has yet to be verified in any of these cases.
When any of the following symptoms occur and continue for more than three days after receiving the new Coronavirus vaccine, the vaccine patient should contact their attending physician or go to the nearest health centre:
- Dizziness
- Extreme and persistent headache
- Nausea or vomiting
- Vision impairment
- Difficult to breath
- Severe chest pain
